Agenus (AGEN) Asset Writedowns and Impairment (2011 - 2023)
Agenus' (AGEN) quarterly Asset Writedowns and Impairment came in at $1.4 million in Q4 2023, up 329.52% quarter-over-quarter from $332000.0 in Q3 2023.
Agenus (AGEN) Asset Writedowns and Impairment (2011 - 2023) Analysis & Trends
Agenus' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $1.4 million for Q4 2023.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $1.4 million in Q4 2023; TTM through Dec 2023 was $2.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $234000.0, down 88.14% from the prior year.
- Asset Writedowns and Impairment improved to $1.4 million in Q4 2023 per AGEN's latest filing, from $332000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.4 million in Q4 2023 and bottomed at $332000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Agenus | 233.53 Mn | 198.53 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.43 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Sep 30, 2023 | 332,000.00 |
| Sep 30, 2023 | 332,000.00 |
| Jun 30, 2015 | 299,345.00 |
| Jun 30, 2015 | 299,345.00 |
| Mar 31, 2015 | 203,347.00 |
| Mar 31, 2015 | 203,347.00 |
| Dec 31, 2014 | 158,193.00 |
| Dec 31, 2014 | 158,193.00 |
| Sep 30, 2014 | 154,772.00 |
| Sep 30, 2014 | 154,772.00 |
| Jun 30, 2014 | 153,735.00 |
| Jun 30, 2014 | 153,735.00 |
| Mar 31, 2014 | 153,146.00 |
| Mar 31, 2014 | 153,146.00 |
| Dec 31, 2013 | 144,360.00 |
| Dec 31, 2013 | 144,360.00 |
| Sep 30, 2013 | 134,704.00 |
| Sep 30, 2013 | 134,704.00 |